Concepedia

Cheryl Silberman

CS

Statistics

Publications

6

Citations

886

H-Index

6

Active since

2000

Affiliations

AstraZeneca (United States)(Current)

AstraZeneca (United Kingdom)

Endeavor Health

Cheryl Silberman is an author at AstraZeneca (United States) specializing in medicine, diabetes mellitus, and pulmonary function testing.

Publications per year

2000–2010

6

Publications

6

What is a clinically meaningful change on the Functional Assessment of Cancer Therapy–Lung (FACT-L) Questionnaire?Results from Eastern Cooperative Oncology Group (ECOG) Study 5592

David Cella, David T. Eton, Diane L. Fairclough et al. · Journal of Clinical Epidemiology · 2002 · 381 citations

, , +14

The Prevalence of COPD

Paul Stang, Eva Lydick, Cheryl Silberman et al. · CHEST Journal · 2000 · 205 citations

, , +8

Weight Loss, Glycemic Control, and Changes in Cardiovascular Biomarkers in Patients With Type 2 Diabetes Receiving Incretin Therapies or Insulin in a Large Cohort Database

Edward S. Horton, Cheryl Silberman, Keith L. Davis et al. · Diabetes Care · 2010 · 155 citations · Full text

, , +17

Prevalence of abnormal serum alanine aminotransferase levels in obese patients and patients with type 2 diabetes

John R. Erbey, Cheryl Silberman, Eva Lydick · The American Journal of Medicine · 2000 · 100 citations

, , +7

Validation of the Functional Assessment of Cancer Therapy-Breast Symptom Index (FBSI)

Kathleen J. Yost, Susan Yount, David T. Eton et al. · Breast Cancer Research and Treatment · 2005 · 28 citations

, , +3

1–5 of 6